title: Baclofen for narcolepsy with cataplexy: two cases.
abstract: Narcolepsy is a disabling sleep disorder characterized by daytime hypersomnolence. Those with cataplexy have spells of muscle weakness precipitated by strong emotions, especially laughter or surprise. Cataplexy treatments include antidepressants or a GABA-B agonist, gamma hydroxybutyrate (GHB). GHB is the most effective treatment for cataplexy, but is expensive and can have significant side effects. A recent report of a murine model of narcolepsy-cataplexy suggests R-baclofen has potential efficacy against cataplexy. We report on two narcolepsy patients with multiple daily cataplexy episodes, one of whom had been effectively treated with GHB, but had to discontinue it for unrelated medical reasons. Both subsequently tried baclofen and experienced almost complete resolution of cataplexy. This report suggests baclofen can be an effective treatment for cataplexy in humans and warrants further study.
authors.affiliation: Department of Psychiatry, Faculty of Medicine, Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada ; Royal Ottawa Mental Health Center, Ottawa, ON, Canada.
authors.forename: Elliott Kyung
authors.initials: EK
authors.lastname: Lee
authors.affiliation: Department of Psychiatry, Faculty of Medicine, Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada ; Royal Ottawa Mental Health Center, Ottawa, ON, Canada.
authors.forename: Alan Bruce
authors.initials: AB
authors.lastname: Douglass
keywords: excessive daytime sleepiness; gamma hydroxybutyrate; hypersomnolence